Chronic hepatitis C: Burden of disease and cost associated with hospitalisations in France in 2012 (The HEPC-LONE study)

Armand Abergel1,2, Michel Rotily3, Sébastien Branchoux4, Raoudha Akremi5, Lucie de Léotoing6, Alexandre Vainchtock6, Anne-Françoise Gaudin4
1Department of Digestive Medicine, CHU Estaing, Clermont-Ferrand, France
2Unité mixte de recherche Université d’Auvergne CNRS 6284, France
3Department of Geriatric Medicine, Centre Hospitalier du Pays d’Aix, Aix-en-Provence, France
4Health Economics and Outcomes Research, Laboratoire Bristol-Myers Squibb, 3, rue Joseph-Monier, 92500 Rueil-Malmaison, France
5Medical Affairs, Laboratoire Bristol-Myers Squibb, 3, rue Joseph-Monier, 92500 Rueil-Malmaison, France
6HEVA, Lyon, France

Tài liệu tham khảo

Te, 2010, Epidemiology of hepatitis B and C viruses: a global overview, Clin Liver Dis, 14, 1, 10.1016/j.cld.2009.11.009 Meffre, 2006 Delarocque-Astagneau, 2010, The impact of the prevention programme of hepatitis C over more than a decade: the French experience, J Viral Hepat, 17, 435, 10.1111/j.1365-2893.2009.01196.x Leleu, 2013, Modeling the epidemiological impact of upcoming direct antiviral agents in hepatitis C treatment, Hepatology, 58, 748A Dhumeaux, 2014 World Health Organization, 2004 Marcellin, 2008, Mortality related to chronic hepatitis B and chronic hepatitis C in France: evidence for the role of HIV coinfection and alcohol consumption, J Hepatol, 48, 200, 10.1016/j.jhep.2007.09.010 Muhlberger, 2009, HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality, BMC Public Health, 9, 34, 10.1186/1471-2458-9-34 Burra, 2009, Hepatitis C, Semin Liver Dis, 29, 53, 10.1055/s-0029-1192055 Lauer, 2001, Hepatitis C virus infection, N Engl J Med, 345, 41, 10.1056/NEJM200107053450107 Agence de la biomédecine, 2013 Deuffic-Burban, 2014, Should we await IFN-free regimens to treat HCV genotype 1 treatment-naive patients? A cost-effectiveness analysis (ANRS 95141), J Hepatol, 61, 7, 10.1016/j.jhep.2014.03.011 Rotily, 2013, How did chronic hepatitis C impact costs related to hospital health care in France in 2009?, Clin Res Hepatol Gastroenterol, 37, 365, 10.1016/j.clinre.2012.11.004 Feeney, 2014, Antiviral treatment of hepatitis C, BMJ, 348, g3308, 10.1136/bmj.g3308 Septfons, 2014, Prévalence, morbidité et mortalité associées aux hépatites B et C chroniques dans la population hospitalisée en France, 2004-2011, Bull Epidémiol Hebd, 12, 202 World Health Organization, 2010 Ministère des Affaires Sociales et de la Santé, 2014 Schwarzinger, 2015, The confounding role of severe comorbidities and alcohol use disorders on prognosis in chronic hepatitis C virus infection: an analysis of the 2008-2012 French national hospital discharge database, J Hepatol, 62, S237, 10.1016/S0168-8278(15)30104-5 Pioche, 2014 Deuffic-Burban, 2008, Impact of viral eradication on mortality related to hepatitis C: a modeling approach in France, J Hepatol, 49, 175, 10.1016/j.jhep.2008.04.012